Quantcast

Latest Highland Therapeutics Inc. Stories

2014-04-28 08:32:18

TORONTO, April 28, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), an emerging pharmaceutical company, today announced that its wholly owned subsidiary has begun enrolment in a Phase III study of HLD-200, the Company's novel formulation of methylphenidate, in pediatric patients with Attention-Deficit Hyperactivity Disorder ("ADHD"). The study, "A Phase III Clinical Endpoint Evaluation Study ("CEES") Examining the Safety and Efficacy of HLD-200 in Pediatric Subjects with...

2014-02-25 08:32:17

TORONTO, Feb. 25, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), an emerging pharmaceutical company, today announced that the Company's President and Chief Executive Officer, David Lickrish, will present at the 34(th) Annual Cowen and Company Health Care Conference at the Boston Marriott Copley Place in Boston, MA. Highland's presentation is scheduled for Monday, March 3, 2014 at 11:00am EST. A live webcast of the presentation can be accessed by visiting...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related